0001562180-20-007087.txt : 20201204
0001562180-20-007087.hdr.sgml : 20201204
20201204165717
ACCESSION NUMBER: 0001562180-20-007087
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201202
FILED AS OF DATE: 20201204
DATE AS OF CHANGE: 20201204
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BRODERICK PATRICK A
CENTRAL INDEX KEY: 0001233220
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36545
FILM NUMBER: 201370477
MAIL ADDRESS:
STREET 1: C/O INTERSECT ENT, INC.
STREET 2: 1555 ADAMS DRIVE
CITY: MENLO PARK
STATE: CA
ZIP: 94025
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Intersect ENT, Inc.
CENTRAL INDEX KEY: 0001271214
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 200280837
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1555 ADAMS DRIVE
CITY: MENLO PARK
STATE: CA
ZIP: 94025
BUSINESS PHONE: 650-641-2100
MAIL ADDRESS:
STREET 1: 1555 ADAMS DRIVE
CITY: MENLO PARK
STATE: CA
ZIP: 94025
FORMER COMPANY:
FORMER CONFORMED NAME: SINEXUS INC
DATE OF NAME CHANGE: 20031124
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2020-12-02
false
0001271214
Intersect ENT, Inc.
XENT
0001233220
BRODERICK PATRICK A
C/O INTERSECT ENT, INC.
1555 ADAMS DRIVE
MENLO PARK
CA
94025
false
true
false
false
EVP, GC & Corporate Secretary
Common Stock
2020-12-02
4
A
false
24156.00
0.00
A
24156.00
D
Stock Options (Right to buy)
19.89
2020-12-02
4
A
false
44989.00
0.00
A
2030-12-01
Common Stock
44989.00
44989.00
D
Represents restricted stock units granted pursuant to the Intersect ENT, Inc. 2014 Equity Incentive Plan. Each restricted stock unit represents a right to receive one share of Intersect ENT, Inc. common stock upon vesting. The restricted stock units vest in three equal annual installments commencing one year after the Vesting Commencement Date of November 30, 2020.
Restricted stock units.
The vesting commencement date of the option is November 30, 2020. 1/4th of the shares subject to the option shall vest on November 30, 2021 and 1/48th of the shares subject to the option shall vest monthly thereafter over 36 months.
/s/ Patrick A. Broderick
2020-12-04